Tag: omalizumab

Biologics in Severe Asthma: How Anti-IgE and Anti-IL-5 Therapies Work

Anti-IgE and anti-IL-5 biologics offer targeted treatment for severe asthma when inhalers fail. They reduce flare-ups by up to 60%, cut steroid use, and improve quality of life-but only for patients with the right biomarkers.

Read More